DOCSLIB.ORG

Online Supporting Information S2: Proteins in Each Negative Pathway

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Online Supporting Information S2: Proteins in Each Negative Pathway Online Supporting Information S2: Proteins in each negative pathway Index Proteins ADO,ACTA1,DEGS2,EPHA3,EPHB4,EPHX2,EPOR,EREG,FTH1,GAD1,HTR6, IGF1R,KIR2DL4,NCR3,NME7,NOTCH1,OR10S1,OR2T33,OR56B4,OR7A10, Negative_1 OR8G1,PDGFC,PLCZ1,PROC,PRPS2,PTAFR,SGPP2,STMN1,VDAC3,ATP6V0 A1,MAPKAPK2 DCC,IDS,VTN,ACTN2,AKR1B10,CACNA1A,CHIA,DAAM2,FUT5,GCLM,GNAZ Negative_2 ,ITPA,NEU4,NTF3,OR10A3,PAPSS1,PARD3,PLOD1,RGS3,SCLY,SHC1,TN FRSF4,TP53 Negative_3 DAO,CACNA1D,HMGCS2,LAMB4,OR56A3,PRKCQ,SLC25A5 IL5,LHB,PGD,ADCY3,ALDH1A3,ATP13A2,BUB3,CD244,CYFIP2,EPHX2,F CER1G,FGD1,FGF4,FZD9,HSD17B7,IL6R,ITGAV,LEFTY1,LIPG,MAN1C1, Negative_4 MPDZ,PGM1,PGM3,PIGM,PLD1,PPP3CC,TBXAS1,TKTL2,TPH2,YWHAQ,PPP 1R12A HK2,MOS,TKT,TNN,B3GALT4,B3GAT3,CASP7,CDH1,CYFIP1,EFNA5,EXTL 1,FCGR3B,FGF20,GSTA5,GUK1,HSD3B7,ITGB4,MCM6,MYH3,NOD1,OR10H Negative_5 1,OR1C1,OR1E1,OR4C11,OR56A3,PPA1,PRKAA1,PRKAB2,RDH5,SLC27A1 ,SLC2A4,SMPD2,STK36,THBS1,SERPINC1 TNR,ATP5A1,CNGB1,CX3CL1,DEGS1,DNMT3B,EFNB2,FMO2,GUCY1B3,JAG Negative_6 2,LARS2,NUMB,PCCB,PGAM1,PLA2G1B,PLOD2,PRDX6,PRPS1,RFXANK FER,MVD,PAH,ACTC1,ADCY4,ADCY8,CBR3,CLDN16,CPT1A,DDOST,DDX56 ,DKK1,EFNB1,EPHA8,FCGR3A,GLS2,GSTM1,GZMB,HADHA,IL13RA2,KIR2 Negative_7 DS4,KLRK1,LAMB4,LGMN,MAGI1,NUDT2,OR13A1,OR1I1,OR4D11,OR4X2, OR6K2,OR8B4,OXCT1,PIK3R4,PPM1A,PRKAG3,SELP,SPHK2,SUCLG1,TAS 1R2,TAS1R3,THY1,TUBA1C,ZIC2,AASDHPPT,SERPIND1 MTR,ACAT2,ADCY2,ATP5D,BMPR1A,CACNA1E,CD38,CYP2A7,DDIT4,EXTL Negative_8 1,FCER1G,FGD3,FZD5,ITGAM,MAPK8,NR4A1,OR10V1,OR4F17,OR52D1,O R8J3,PLD1,PPA1,PSEN2,SKP1,TACR3,VNN1,CTNNBIP1 APAF1,APOA1,CARD11,CCDC6,CSF3R,CYP4F2,DAPK1,FLOT1,GSTM1,IL2 Negative_9 2,KLRK1,LARS,NGEF,OR7A17,PFN3,PIGL,POLR2E,PPCS,RAF1,SEMA3C, SULT1A4,TAS1R1,TCF7L1,TRMT11,XIAP,TNFRSF6B LPL,ADORA2A,ATP6V1H,B3GALT1,CLTCL1,CNGA4,DTX3L,IL23R,IRF5,N Negative_10 EU2,OR4M1,RDH12,SEMA4F,STAT5A,THBS4 AGL,CBS,FUK,ACSS1,ALAS2,ASAH1,ATP2A2,CD14,CD44,CLDN17,CYP1A 1,DDX23,DNMT1,EFNA4,ENPP7,EPOR,EXTL1,FLT1,GFPT1,GRIA1,HAO1, Negative_11 HTR2A,IFNA4,LEFTY2,MTHFD2,NCR2,OR10A2,OR1L6,OR2L3,OR51M1,OR 5B12,OR5M3,OR6C1,ORC3L,PLA2G2E,PLCB2,PTCH1,TAS1R2,ULK2,ATP6 V0A2,CACNA2D3 BID,BPNT1,CACNA1D,CXCL16,ENPP7,EPHA1,FUT4,GMPS,GRIN2C,IBSP, Negative_12 IL22,IL2RA,LLGL2,MAPK13,MTFMT,MTHFR,NOS3,OR56A1,PAK2,PIGU,P LCZ1,POLR3B,PTPN6,RAPGEF4,TUBA8,TUBB1,TNFRSF12A EGF,LTB,ACAT2,ADCY10,CCL26,CCNB3,CLDN1,DGAT2L4,DVL1,FBP1,IF NK,ITGAE,LAMA4,MCCC2,NEU3,NKD1,NLGN1,NT5C2,OR10H4,OR1L4,OR2 Negative_13 A42,OR2AE1,OR2Z1,OR4K1,OR51F2,OR5AK2,OR5V1,OR9G4,PDE1C,PIAS 2,PPAP2C,PPP1R1A,RBL1,ROBO1,SEMA4C,THBD,TUBA1B,B4GALNT1,HSD 17B10,TNFRSF18 MOS,OSM,WAS,AASDH,B3GALT2,B4GALT1,CDKN2A,CLDN19,DDX50,ENTPD Negative_14 3,F2RL1,GALNTL4,GNA13,HIF1A,IL12RB2,NAE1,NKD1,OR1J1,OR2M4,O R9I1,PLOD1,PLXNB1,SDHC,SH3BP2,STX6,TOLLIP,TUBB2B ADK,CFH,DAO,F9,MUT,ADCY5,ADH1A,ALDH1L1,CARS2,CD14,CD79A,CTB S,CYP2A7,DGKH,DUSP10,DUSP16,DUSP5,DVL2,FGF21,GALM,GNAI1,GST Negative_15 A2,HADHA,IDH1,IFNK,LDHD,LFNG,LTA4H,MASP1,OR10G8,OR51G2,PAX4 ,PIM1,RND1,TKTL2,TLR9,TNFRSF17 FUK,GH1,SPN,ACSM4,CACNB1,CACNB2,CCDC6,CCR4,CDK2,CKS1B,EHHAD H,FADS2,GALNT12,GRIA1,HCLS1,HIF1A,HMGCS1,HMGCS2,IL3RA,ITPA, Negative_16 KCNB1,MAP2K6,MAPK8,MTHFR,MYH2,NTF4,OR10A5,OR1C1,OR1J2,OR2T1 0,OR52L1,OR5AK2,PDE8A,PIGM,PIK3CA,PIP5K3,PLCG1,POLE,SHC1,SK IV2L2,SV2B,TJP1,TKTL1,TUBA3C,UROC1,HLA-DPA1 Negative_17 CALML6,CDKN1B,EFNA3,OR2T4 ME3,ACOX3,ADORA2B,AKR1C2,ALDH9A1,ATP5F1,B3GAT3,BAIAP2,BMP8A ,CXCL3,CYP1B1,DHRS4L2,HADHB,IDH1,IRS1,KLRC4,MAN1A1,MAP3K4,N Negative_18 KX6- 1,OR1Q1,OR2B6,OR2H1,OR7G3,PDE1A,PECAM1,PGAM4,PIGX,PPP2CB,PP T1,RHEB,SLC2A4,SV2C,SYNJ1,TAP1,UGCGL1,WNT7B CAT,CDA,LEP,PTS,B3GNT4,BLVRB,CLDN20,COASY,COL4A2,CTNNA2,EFN A1,FGF13,GALE,GBA3,GCNT3,GSTM4,HSD17B3,IL12RB1,IL2RB,IPPK,L Negative_19 RDD,MYH9,NOX1,NTF3,OR14C36,OR2T2,OR4K13,OR4N4,OR56A1,PDE3B, PIP4K2A,PTGFR,QARS,SPHK2,STK3,TP73,TUBA8,TUBB2A AR,C8B,CTH,IL9,ALDH1A1,ALOX5,BCL10,CACNB4,CDC25C,FOXO1,GALT Negative_20 ,GRIN2C,GSTT1,HAP1,IDI2,IL20,NRXN1,OR10C1,OR3A1,OR4K5,OR51Q 1,OR7G2,OR8D1,ORC4L,PER3,PIAS4,SPRY4,UGCGL1,YWHAZ,ATP6V1B2 FMO3,GSK3B,HLA- Negative_21 F,NPAS2,NTSR1,OR1I1,OR1L1,OR1Q1,OR52M1,P2RX4,POLD4,POLE4,ST X5,TNFRSF12A PC,AASDH,ACP6,ALDH7A1,ASRGL1,CCR3,CDC16,CDH2,CNGB1,COL4A6,D RD1,EFNB2,EIF4E2,FARS2,FBP1,GLI3,GNAI2,GRIN2C,GUCY1B3,HAO1, Negative_22 HNF1B,OR6C6,OR7G1,PIK3R5,PPP3CC,PRNP,RASSF5,SLC9A1,ST3GAL5, TGFBR1,WNT9A,XCL1,YARS ADA,C8G,IL8,AGPAT2,AMD1,CCKAR,COMP,DAPK2,EPHA2,GYS1,OR10J5, Negative_23 OR10K2,OR1L6,OR51T1,OR6B3,PARD6A,PDE2A,PPARA,RAPGEF2,RHOQ,S ETDB1,SMPD4 AGK,FH,GPT,IL4,ARRB2,ATP6AP1,B3GALT6,CASP10,CCL24,CFLAR,CYP 2A6,EPHA6,FGF1,FLT4,GALC,HBEGF,HSPA8,ITGAX,KNG1,MAP3K14,MAP Negative_24 K1,MGST2,MTFMT,NT5C1A,OR2A25,OR2L8,OR51G2,PKMYT1,POLD4,POLR 3D,PPP1R3C,PRNP,PTGS1,RAC3,RASGRP2,RPIA,RPS6KB2,SLC33A1,ST3 GAL3,STAT5B,TAS1R3,TLN2,ULK1 CKM,PDC,ALG5,ALPL,ANAPC4,ARSD,ATP5O,BDH2,BMP5,CAV2,CES1,CXC L11,DHRS4,GALE,GAMT,HSD11B2,IFNA16,IMPDH1,IRAK3,MAP2K1,MAPK Negative_25 1,NADSYN1,OR13F1,OR3A1,OR52A5,OR5AK2,OR5P2,PDGFD,PIGT,PIPOX ,PLAT,PNPLA4,PPM1B,PPP1R3C,RND1,RRM1,SEMA4A,TPH2,USE1,WNT5A ,CACNA2D2,GABARAPL2,PRICKLE2 ADIPOR1,ALOX12,ALOX5,ATP5J,BCL2,CALML5,CD36,CFLAR,CLDN14,CR EB3L1,CXCL9,CYP19A1,DPYD,ECSIT,EGFR,EPHA6,GALNT6,GBGT1,GCLM ,HCLS1,KIR2DS4,KLKB1,LDHB,LHCGR,LIPC,LMO7,MAP2K3,MPST,NCF1, Negative_26 NRXN2,NT5C2,OGDHL,OR1B1,OR2T34,OR2W1,OR6A2,OR8B4,PIK3CG,PKM YT1,RDH8,SLC9A1,SMAD2,SMAD7,SPCS1,TAS2R42,TUBB2A,TUBB3,UCKL 1,HLA-DQB1 IHH,ACAT2,BTRC,CDC6,CKS1B,CNTF,CREBBP,DRD1,GAPDH,GBA3,GIT1, GSTM1,ITGA11,JAK2,MOV10L1,NCOA4,ONECUT1,OR10C1,OR10S1,OR2T2 Negative_27 ,OR4K2,OR4M1,OR6C2,OR8G1,P2RX7,PFKFB3,PGAP1,PLXNC1,PPARA,PR KAA2,PRNP,PTPN11,SETD1A,SMARCA5,STK36,TGFB3,VAV3,XCL1,PDCD1 LG2,PHOSPHO1 DCK,ID3,IVD,AKT3,APAF1,ARPC1A,B3GALT5,BIRC2,CACNB3,CREB3,CR KL,CX3CL1,CYP3A7,DTX4,FRAT2,GCLM,GMPS,GNPAT,GSTO1,GZMB,HNF1 Negative_28 A,MAPK12,NAGS,NEUROG3,NUDT2,OR10G2,OR1A1,OR4N5,OR51A4,OR51G 2,OR9Q1,OXCT2,PI4KB,PTGS2,RFXAP,RPS6KB1,RUNX1,SHC1,SLC9A1,S PHK1,SRD5A1,TNFSF18,UGT2A1,WNT16,WNT3A Negative_29 AARS2,ACSM1,C3AR1,OR5D13,SGMS2,TNFRSF14 Negative_30 C3AR1,PIP5K1A,UGCGL2 C4B,ACACA,ADCY2,ADIPOQ,CCL11,CD34,DDX54,DTX3,DTX4,ELK1,HAGH L,HEMK1,INPP5B,ITGB1,JAM2,LIAS,MAPK13,MAT2B,MPDZ,MTFMT,OR5A Negative_31 R1,OR6C75,OR6K2,OR7G1,OXTR,PDE2A,PHGDH,PIGO,PYCR2,RALA,RRM1 ,SETDB2,SH2D1B,SKP1,STAT2 Negative_32 CCL20,FUT6,ITGAE,OR2B6,OR5T3,PEMT,PPA1,PPP1CB,GABARAPL2 ME3,TNC,BACE2,C1QA,CASP8,CCNB1,CLDN7,COQ7,CRKL,CYP2A7,CYP2C 9,CYP3A5,CYSLTR2,DAD1,DVL3,GALK1,GNPNAT1,HLA- Negative_33 DRA,IFNA10,INHBE,MAPT,MTHFD1,MYH6,OR1B1,OR2T2,OR4C16,OR5D16 ,PDE4B,PDGFA,PIK3R5,PRKAA2,RALA,RAPGEF1,SESN2,SLIT1,STX2,TG FB3,TJP2,UGT2B10,WHSC1,WNT7A F11,FAH,FUK,ACAA2,ACTB,ACVR1C,ADCY6,AGRP,ATP5E,BLNK,CCNB1,C NTNAP1,DAPK3,DHRS4,ENTPD4,EPHA6,GNPAT,GZMA,HLA- Negative_34 DRA,HNF4G,ITGB3,MMP9,NCOR1,OR11H4,OR2V2,PANK2,PIGK,POLE3,PO LR3D,PPP2R1B,PPP2R5E,PTK2B,RAP1A,TACR1,TRADD,UGP2,UNC5D,WAR S,EIF4EBP1,KIR2DL5A F11,JUN,SFN,SMO,CACNA1F,CREBBP,GAD2,OR13H1,OR8A1,PARS2,PIP5 Negative_35 K1C,POLE4,POLR2L,POLR3B,SESN1,UGP2 C8G,F10,FOS,ACTN2,ARG1,C4BPA,CACNB2,CCNG2,CD226,CD3E,CD99,C HD8,CPT1C,CSF1R,CSF2,CYP21A2,DERL1,DGKB,DUSP3,EI24,FGF9,IDI Negative_36 2,IFNA16,IL10RA,ITGA8,KLRD1,MAD2L1,MTHFD1L,MYH11,NRXN3,NT5M ,OR1M1,OR52H1,PAK2,RASA1,RDH10,SETDB1,STX5,TICAM1,TOMM40L,U GCGL1,UNC5B,YES1,ZMAT3 Negative_37 MVD,CX3CR1,METTL6,OR4D5,RBKS,RPRM,RRAS2,SLC25A5 LAT,ADCY3,ARPC5L,ATG12,CD46,CDKN2D,COL1A1,DEGS1,DUSP5,HRAS, Negative_38 IKBKE,LDHD,MAP4K2,NFYC,PLXNB3,RBL1,SPRED2,SSH3,TJP2,VAMP1 CS,LTB,AARS,ABLIM2,ACOX3,AGPAT1,AGRN,ALDH1A3,ALG6,AMPD3,BBO X1,CAV2,CREBBP,CYP11B2,CYP2F1,EDAR,GNAI2,HPRT1,HSD17B4,IKBK E,LDHAL6B,MYH8,MYL5,NCKAP1,NT5C1A,OR2T11,OR51B4,OR52W1,OR6X Negative_39 1,OR8H3,PCYT1B,PDE3B,PIGV,PLOD3,POLR2K,POLR3G,PPP1R1A,PPP2R 2D,PRKACB,RBPJL,RPS6KB1,STK11,SUCLA2,TJP1,TUBB1,TUBB4,UGDH, VCAM1,SERPINC1 ADC,ACSL5,ACTN2,ATP5E,CHST11,EXOC7,FOXO1,FZD4,FZD7,HADHB,HI Negative_40 F1A,ITGAE,MARS,OR14I1,OR4K17,PDE8A,PLCE1,PMM2,SNW1,SYNJ1,WN T4,CTNNBIP1 CFI,CGN,FOS,MVD,RFK,ACPP,ADRA1A,ARHGEF6,CCKAR,CCR8,CD72,DUS P1,EPHA7,EXT1,FGF2,G6PD,GSTA4,HPSE,HSD11B2,HSD3B2,IFNA10,IL Negative_41 10,IPMK,LLGL1,MARS2,MDH2,MYH14,NCOA4,NFATC2,NRG2,OR10AG1,OR 52E2,OR5L2,OR8J3,PDHA2,PPAP2A,PTPRB,RALGDS,RFX5,RPS6KA3,SDC 4,TJP3,TRAF3,UNC5D,TNFRSF10B C3,F12,AARS,ADCY4,ADH5,ADORA2A,ADRA1D,ALDOA,ALG3,CNGB1,CNTF R,CXCL5,CXCR4,DGKA,DGUOK,EFNB3,F2RL2,FASLG,GDF6,GMPR,GMPS,G Negative_42 NAQ,IFNA14,IL23R,ITGAE,MAP3K14,MMP9,NAGLU,NEFH,OCRL,OR10G4, OR6S1,PCCB,PRKAA2,PSEN2,RFX5,SC4MOL,UGCG,SUV420H1 AK1,BAD,AADAC,ACLY,CLDN11,DDB2,GPT2,MYH10,PFKFB4,SPTLC2,TLR Negative_43 9 ABO,LYN,SFN,SPN,ACTG2,ADH5,ALOX15B,BACE1,CDC2,CNTF,DDX23,IL 19,INPP5E,KIR2DL2,KIR3DL2,MAP3K3,NEU4,NKX2- Negative_44 2,NTRK1,OR2Y1,OR8B4,PDE9A,RALGDS,RASGRP1,ROBO1,ST8SIA5,TAS2 R3,TLR2,TNFRSF4,TUBB4,UCP1,VEGFB AK1,GSR,NLK,SYK,UBC,ACSM1,ALDH5A1,ALPPL2,B3GALT1,B4GALT1,C1 QB,CCNG1,CCR6,CD28,CD46,CDC25A,CTNNA1,DAPK2,DDX55,DUSP10,DU Negative_45 SP3,EPHA1,ETNK2,FABP4,FLOT2,HTR5A,IFNA7,IL1B,MAFA,MDM2,NRXN 2,OR4D1,PHKA1,PLA2G6,PON3,RDH5,RFWD2,SIPA1,SMAD7,SPRY2,SRGA P3,TLR9,TSTA3,PAFAH1B3 Negative_46 APOA1,CD19,OR10P1,RAC1 PGD,TXK,ACSM4,ARHGEF2,ARPC5L,CACNA1A,CAMKK2,COL4A2,CSAD,E2F Negative_47 3,EFNA1,GNAQ,GNPDA2,HLA- DRA,ITGB1,OR1C1,OR1E2,PIK3R5,TUBB2C,ATP6V1G1,CACNA2D1 LTB,ACLY,B3GALT4,CREB3L2,CYP2F1,DHRS3,EPB41,GUCY2F,HSPA1B,I Negative_48 L12B,LIPC,MTMR6,NFYB,OR1B1,OR1D5,OR4A16,PIGW,SARDH,UGCGL2,Y KT6,B3GALNT1 AK3,MAX,ADCY8,BCL2L1,BST1,CXCR5,CYP2J2,IL1R2,INPP5E,LAMB2,M Negative_49 BL2,MYH15,MYL9,NARS2,OR13C3,RASGRF2,RASGRP1,SHC3,SPRY3,GABA RAPL2,SERPINF2 ID2,ACMSD,CAMKK1,CCL28,CDC45L,CYCS,DAAM2,DCTN1,DOT1L,DUSP2, ENPP3,GDF6,IL12A,LAMB4,NAMPT,NEUROD1,OR4D5,PLA2G2D,PLXNA3,P Negative_50 OLR2D,PPAP2B,PRKAB2,PRKACA,PRKAR1B,PTPRJ,RDH8,SETD1B,TNFSF1 4,TUBB2B,VASP GLS,ALDH4A1,ALOX15,ATP2A3,CPT2,CYBA,ELK4,FABP4,HADHB,IL8RB, Negative_51 IMPA1,ITGA6,NLGN3,NT5M,OR2L3,OR52R1,OR6B2,P2RX6,PGK2,PRKACB
Load more

  1785
Copy Link
Recommended publications
  • CRISPR Screening of Porcine Sgrna Library Identifies Host Factors
    ARTICLE https://doi.org/10.1038/s41467-020-18936-1 OPEN CRISPR screening of porcine sgRNA library identifies host factors associated with Japanese encephalitis virus replication Changzhi Zhao1,5, Hailong Liu1,5, Tianhe Xiao1,5, Zichang Wang1, Xiongwei Nie1, Xinyun Li1,2, Ping Qian2,3, Liuxing Qin3, Xiaosong Han1, Jinfu Zhang1, Jinxue Ruan1, Mengjin Zhu1,2, Yi-Liang Miao 1,2, Bo Zuo1,2, ✉ ✉ Kui Yang4, Shengsong Xie 1,2 & Shuhong Zhao 1,2 1234567890():,; Japanese encephalitis virus (JEV) is a mosquito-borne zoonotic flavivirus that causes ence- phalitis and reproductive disorders in mammalian species. However, the host factors critical for its entry, replication, and assembly are poorly understood. Here, we design a porcine genome-scale CRISPR/Cas9 knockout (PigGeCKO) library containing 85,674 single guide RNAs targeting 17,743 protein-coding genes, 11,053 long ncRNAs, and 551 microRNAs. Subsequently, we use the PigGeCKO library to identify key host factors facilitating JEV infection in porcine cells. Several previously unreported genes required for JEV infection are highly enriched post-JEV selection. We conduct follow-up studies to verify the dependency of JEV on these genes, and identify functional contributions for six of the many candidate JEV- related host genes, including EMC3 and CALR. Additionally, we identify that four genes associated with heparan sulfate proteoglycans (HSPGs) metabolism, specifically those responsible for HSPGs sulfurylation, facilitate JEV entry into porcine cells. Thus, beyond our development of the largest CRISPR-based functional genomic screening platform for pig research to date, this study identifies multiple potentially vulnerable targets for the devel- opment of medical and breeding technologies to treat and prevent diseases caused by JEV.
    [Show full text]
  • Deep Learning–Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer Kumardeep Chaudhary1, Olivier B
    Published OnlineFirst October 5, 2017; DOI: 10.1158/1078-0432.CCR-17-0853 Statistics in CCR Clinical Cancer Research Deep Learning–Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer Kumardeep Chaudhary1, Olivier B. Poirion1, Liangqun Lu1,2, and Lana X. Garmire1,2 Abstract Identifying robust survival subgroups of hepatocellular car- index (C-index) ¼ 0.68]. More aggressive subtype is associated cinoma (HCC) will significantly improve patient care. Current- with frequent TP53 inactivation mutations, higher expression ly, endeavor of integrating multi-omicsdatatoexplicitlypredict of stemness markers (KRT19 and EPCAM)andtumormarker HCC survival from multiple patient cohorts is lacking. To fill BIRC5, and activated Wnt and Akt signaling pathways. We this gap, we present a deep learning (DL)–based model on HCC validated this multi-omics model on five external datasets of that robustly differentiates survival subpopulations of patients various omics types: LIRI-JP cohort (n ¼ 230, C-index ¼ 0.75), in six cohorts. We built the DL-based, survival-sensitive model NCI cohort (n ¼ 221, C-index ¼ 0.67), Chinese cohort (n ¼ on 360 HCC patients' data using RNA sequencing (RNA-Seq), 166, C-index ¼ 0.69), E-TABM-36 cohort (n ¼ 40, C-index ¼ miRNA sequencing (miRNA-Seq), and methylation data from 0.77), and Hawaiian cohort (n ¼ 27, C-index ¼ 0.82). This TheCancerGenomeAtlas(TCGA),whichpredictsprognosis is the first study to employ DL to identify multi-omics features as good as an alternative model where genomics and clinical linked to the differential survival of patients with HCC. Given data are both considered. This DL-based model provides two its robustness over multiple cohorts, we expect this workflow to optimal subgroups of patients with significant survival differ- be useful at predicting HCC prognosis prediction.
    [Show full text]
  • Identification of Candidate Substrates of the Leucine Rich Repeat Kinase 2 by Mass Spectrometry
    Identification of candidate substrates of the leucine rich repeat kinase 2 by mass spectrometry- based phosphoproteomics William Carl Edelman A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2016 Reading Committee: Judit Villén, Chair Leo Pallanck Deborah Nickerson Program Authorized to Offer Degree: Department of Genome Sciences 2 © Copyright 2016 William Carl Edelman 3 University of Washington Abstract Identification of candidate substrates of the leucine rich repeat kinase 2 by mass spectrometry-based phosphoproteomics William Carl Edelman Chair of the Supervisory Committee: Assistant Professor, Judit Villén Department of Genome Sciences Mutations in the kinase domain of the leucine rich repeat kinase (LRRK2) have been implicated in heritable forms of Parkinson’s disease (PD). Specifically, a glycine to serine mutation (G2019S) has demonstrated hyperactive autophosphorylation, neuronal toxicity, and locomotor deficits in the fruit fly Drosophila melanogaster— all of which are related to its pathogenicity in PD. My dissertation focuses on identifying novel substrates of LRRK2 through analysis of proteome-wide changes in protein abundance as well as identifying changes in phosphorylation of proteins in vitro and in the in vivo fruit fly model. Using mass spectrometry, I provide quantitative information on thousands of proteins and phosphorylation sites. In vitro kinase assays on peptides derived from fly heads or a neuroblastoma cell line provide evidence for direct substrates of LRRK2, while the in vivo experiment in flies expressing LRRK2 identifies both direct and indirect phosphorylation substrates of the kinase. Herein, I present evidence for novel, LRRK2-mediated phosphorylation sites in the Drosophila melanogaster and the neuroblastoma models of PD.
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • Primary Antibodies Flyer
    Primary Antibodies Your choice of size and format Format Concentration Size CF® dye conjugates (13 colors) 0.1 mg/mL 100 or 500 uL Biotin, HRP or AP conjugates 0.1 mg/mL 100 or 500 uL R-PE, APC, or Per-CP conjugates 0.1 mg/mL 250 uL Purified, with BSA 0.1 mg/mL 100 or 500 uL Purified, BSA-free (Mix-n-Stain™ Ready) 1 mg/mL 50 uL Advantages Figure 1. IHC staining of human prostate Figure 2. Flow cytometry analysis of U937 • More than 1000 monoclonal antibodies carcinoma with anti-ODC1 clone cells with anti-CD31/PECAM clone C31.7, • Growing selection of monoclonal rabbit ODC1/485. CF647 conjugate (blue) or isotype control (orange). antibodies • Validated in IHC and other applications Your choice of 13 bright and photostable CF® dyes • Choose from 13 bright and stable CF® dyes CF® dye Ex/Em (nm) Features • Also available with R-PE, APC, PerCP, HRP, AP, CF®405S 404/431 • Better fit for the 450/50 flow cytometer channel than Alexa Fluor® 405 or biotin CF®405M 408/452 • More photostable than Pacific Blue®, with less green spill-over • Purified antibodies available BSA-free, 1 mg/mL, • Compatible with super-resolution imaging by SIM ready to use for Mix-n-Stain™ labeling or other CF®488A 490/515 • Less non-specific binding and spill-over than Alexa Fluor® 488 conjugation • Very photostable and pH-insensitive • Compatible with super-resolution imaging by TIRF • Offered in affordable 100 uL size CF®543 541/560 • Brighter than Alexa Fluor® 546 CF®555 555/565 • Brighter than Cy®3 • Validated in multicolor super-resolution imaging by STORM CF®568
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Autism Multiplex Family with 16P11.2P12.2 Microduplication Syndrome in Monozygotic Twins and Distal 16P11.2 Deletion in Their Brother
    European Journal of Human Genetics (2012) 20, 540–546 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Autism multiplex family with 16p11.2p12.2 microduplication syndrome in monozygotic twins and distal 16p11.2 deletion in their brother Anne-Claude Tabet1,2,3,4, Marion Pilorge2,3,4, Richard Delorme5,6,Fre´de´rique Amsellem5,6, Jean-Marc Pinard7, Marion Leboyer6,8,9, Alain Verloes10, Brigitte Benzacken1,11,12 and Catalina Betancur*,2,3,4 The pericentromeric region of chromosome 16p is rich in segmental duplications that predispose to rearrangements through non-allelic homologous recombination. Several recurrent copy number variations have been described recently in chromosome 16p. 16p11.2 rearrangements (29.5–30.1 Mb) are associated with autism, intellectual disability (ID) and other neurodevelopmental disorders. Another recognizable but less common microdeletion syndrome in 16p11.2p12.2 (21.4 to 28.5–30.1 Mb) has been described in six individuals with ID, whereas apparently reciprocal duplications, studied by standard cytogenetic and fluorescence in situ hybridization techniques, have been reported in three patients with autism spectrum disorders. Here, we report a multiplex family with three boys affected with autism, including two monozygotic twins carrying a de novo 16p11.2p12.2 duplication of 8.95 Mb (21.28–30.23 Mb) characterized by single-nucleotide polymorphism array, encompassing both the 16p11.2 and 16p11.2p12.2 regions. The twins exhibited autism, severe ID, and dysmorphic features, including a triangular face, deep-set eyes, large and prominent nasal bridge, and tall, slender build. The eldest brother presented with autism, mild ID, early-onset obesity and normal craniofacial features, and carried a smaller, overlapping 16p11.2 microdeletion of 847 kb (28.40–29.25 Mb), inherited from his apparently healthy father.
    [Show full text]
  • The Purification and Identification of Interactors to Elucidate Novel Connections in the HEK 293 Cell Line
    The Purification and Identification of Interactors to Elucidate Novel Connections in the HEK 293 Cell Line Brett Hawley Biochemistry, Microbiology and Immunology Faculty of Medicine University of Ottawa © Brett Hawley, Ottawa, Canada, 2012 ABSTRACT The field of proteomics studies the structure and function of proteins in a large scale and high throughput manner. My work in the field of proteomics focuses on identifying interactions between proteins and discovering novel interactions. The identification of these interactions provides new information on metabolic and disease pathways and the working proteome of a cell. Cells are lysed and purified using antibody based affinity purification followed by digestion and identification using an HPLC coupled to a mass spectrometer. In my studies, I looked at the interaction networks of several AD related genes (Apolipoprotein E, Clusterin variant 1 and 2, Low-density lipoprotein receptor, Phosphatidylinositol binding clathrin assembly protein, Alpha- synuclein and Platelet-activating factor receptor) and an endosomal recycling pathway involved in cholesterol metabolism (Eps15 homology domain 1,2 and 4, Proprotein convertase subtilisin/kexin type 9 and Low-density lipoprotein receptor). Several novel and existing interactors were identified and these interactions were validated using co-immunopurification, which could be the basis for future research. ii ACKNOWLEDGEMENTS I would like to take this opportunity to thank my supervisor, Dr. Daniel Figeys, for his support and guidance throughout my studies in his lab. It was a great experience to work in his lab and I am very thankful I was given the chance to learn and work under him. I would also like to thank the members of my lab for all their assistance in learning new techniques and equipment in the lab.
    [Show full text]
  • Broad and Thematic Remodeling of the Surface Glycoproteome on Isogenic
    bioRxiv preprint doi: https://doi.org/10.1101/808139; this version posted October 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Broad and thematic remodeling of the surface glycoproteome on isogenic cells transformed with driving proliferative oncogenes Kevin K. Leung1,5, Gary M. Wilson2,5, Lisa L. Kirkemo1, Nicholas M. Riley2,4, Joshua J. Coon2,3, James A. Wells1* 1Department of Pharmaceutical Chemistry, UCSF, San Francisco, CA, USA Departments of Chemistry2 and Biomolecular Chemistry3, University of Wisconsin- Madison, Madison, WI, 53706, USA 4Present address Department of Chemistry, Stanford University, Stanford, CA, 94305, USA 5These authors contributed equally *To whom correspondence should be addressed bioRxiv preprint doi: https://doi.org/10.1101/808139; this version posted October 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract: The cell surface proteome, the surfaceome, is the interface for engaging the extracellular space in normal and cancer cells. Here We apply quantitative proteomics of N-linked glycoproteins to reveal how a collection of some 700 surface proteins is dramatically remodeled in an isogenic breast epithelial cell line stably expressing any of six of the most prominent proliferative oncogenes, including the receptor tyrosine kinases, EGFR and HER2, and downstream signaling partners such as KRAS, BRAF, MEK and AKT.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short
    bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Transcriptomic analysis of native versus cultured human and mouse dorsal root ganglia focused on pharmacological targets Short title: Comparative transcriptomics of acutely dissected versus cultured DRGs Andi Wangzhou1, Lisa A. McIlvried2, Candler Paige1, Paulino Barragan-Iglesias1, Carolyn A. Guzman1, Gregory Dussor1, Pradipta R. Ray1,#, Robert W. Gereau IV2, # and Theodore J. Price1, # 1The University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, 800 W Campbell Rd. Richardson, TX, 75080, USA 2Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine # corresponding authors [email protected], [email protected] and [email protected] Funding: NIH grants T32DA007261 (LM); NS065926 and NS102161 (TJP); NS106953 and NS042595 (RWG). The authors declare no conflicts of interest Author Contributions Conceived of the Project: PRR, RWG IV and TJP Performed Experiments: AW, LAM, CP, PB-I Supervised Experiments: GD, RWG IV, TJP Analyzed Data: AW, LAM, CP, CAG, PRR Supervised Bioinformatics Analysis: PRR Drew Figures: AW, PRR Wrote and Edited Manuscript: AW, LAM, CP, GD, PRR, RWG IV, TJP All authors approved the final version of the manuscript. 1 bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • An Endocytosis Pathway Initiated Through Neuropilin-1 and Regulated by Nutrient Availability
    ARTICLE Received 18 Apr 2014 | Accepted 2 Aug 2014 | Published 3 Oct 2014 DOI: 10.1038/ncomms5904 An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability Hong-Bo Pang1, Gary B. Braun1,2, Tomas Friman1,2, Pedro Aza-Blanc1, Manuel E. Ruidiaz1, Kazuki N. Sugahara1,3, Tambet Teesalu1,4 & Erkki Ruoslahti1,2 Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development. Many growth factors and other signalling molecules bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif). Peptides with this motif (CendR peptides) are taken up into cells by endocytosis. Tumour-homing CendR peptides penetrate through tumour tissue and have shown utility in enhancing drug delivery into tumours. Here we show, using RNAi screening and subsequent validation studies, that NRP1-mediated endocytosis of CendR peptides is distinct from known endocytic pathways. Ultrastructurally, CendR endocytosis resembles macropinocytosis, but is mechanistically different. We also show that nutrient-sensing networks such as mTOR signalling regulate CendR endocytosis and subsequent intercellular transport of CendR cargo, both of which are stimulated by nutrient depletion. As CendR is a bulk transport pathway, our results suggest a role for it in nutrient transport; CendR-enhanced drug delivery then makes use of this natural pathway. 1 Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA. 2 Center for Nanomedicine, Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California 93106-9610, USA. 3 Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
    [Show full text]